Zydus Cadila aims to approve the world’s first DNA Covid vaccine

Ahmedabad-based pharmaceutical company Zydus Cadila has asked India’s main regulatory agency to issue limited emergency approval for ZyCovD, a three-dose Covid19 vaccine. If approved, this will be the world’s first DNA vaccine against Covid19

The vaccine was tested in the late stage of human clinical trials with more than 28,000 participants. The initial effective rate was 66.6%, preventing the rise in symptomatic cases of Covid19. The percentage of nearly 67 vaccinated people compared to those who have not been vaccinated.

Although ZyCovD is not as effective as most other Covid19 vaccines approved in India, the advantage of ZyCovD lies in its effectiveness against the delta variant of the virus. Dr. Xavier Patel, Managing Director of Zydus Cadila.

Patel said at a press conference on Thursday: “This study was conducted in 50 different clinical centers across the country during the peak of the second wave of Covid19. This confirmed that the vaccine is effective against a new mutant strain of Delta. The effectiveness of the strain.”

The company is testing vaccines against other worrying options, and based on the results, if other strains become more infectious or virulent, it will decide whether to “modernize” the vaccine.